Latest Breaking News On - Molecular therapy - Page 6 : comparemela.com

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Laura soucekElena garraldaRaquel perez lopezEmiliano calvoRadiomics groupEarly clinical drug development groupExperimental therapeutics programModels of cancer therapies groupCatalan institute of researchUniversity hospitalsResearch unit for molecular therapy of cancerResearch professorTherapeutics programCancer therapies groupCatalan instituteAdvanced studie

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property:A proprietary non-gene editing technology.

United kingdomMont saint guibertWaals gewestCity ofMichel lussierDavid georgesExchange commissionIntellectual propertyChief executive officerCelyad oncologyMolecular therapyNucleic acidsMol ther nucleicPrivate securities litigation reform actAnnual reportOncology contacts

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofMont saint guibertWaals gewestMichel lussierDavid georgesExchange commissionIntellectual propertyChief executive officerCelyad oncologyMolecular therapyNucleic acidsMol ther nucleicPrivate securities litigation reform actAnnual reportOncology contacts

New mechanism with potential to boost checkpoint-blocking cancer immunotherapies identified

New mechanism with potential to boost checkpoint-blocking cancer immunotherapies identified
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Paul kennedyFrank wardLekh dahalPault kennedyMark craggUniversity of southamptonUniversity of aberdeenUniversity of liverpoolCancer immunology centerMolecular therapyCancer immunologyProfessor mark cragg

Dr Leen Kawas Brings Longer Lifespans, Rising Chronic Diseases, and Two Game-Changing Breakthroughs Into Focus

As the healthcare industry evolves, large-scale trends and economies of scale continue to emerge. Leen Kawas, Ph.D., Propel Bio Partners' Managing General Partner, detailed the scope of these developments. She also discussed the continued increase in chronic diseases and autoimmune diseases. Finally, Dr. Kawas profiled two innovative technologies that offer promise for better healthcare delivery and more effective patient treatments.

United statesUnited kingdomSunil ahujaIain mcinnesVeterinary life sciencesDepartment of veterans affairs centerCenters for diseaseUniversity of glasgowWorld health statisticsUnited nationsWorld health organizationNature communicationsPrincipal of the university glasgowLeen kawasPropel bio partner managing generalNecessarily healthier ones